請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/53730
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳秀熙(Hsiu-Hsi Chen) | |
dc.contributor.author | Fu-Chen Liang | en |
dc.contributor.author | 梁富珍 | zh_TW |
dc.date.accessioned | 2021-06-16T02:28:28Z | - |
dc.date.available | 2016-09-14 | |
dc.date.copyright | 2015-09-14 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-08-03 | |
dc.identifier.citation | REFEERENCE
Anna-karin Eriksson, Sofia Lofving et.al, Alcohol use disorder and risk of Parkinson’s disease: finding from a Swedish national cohort study 1972-2008, BMC Neurology 2013, 13:190. Behari M, Srivastava AK, Das RR, Pandey RM. Risk factors of Parkinson's disease in Indian patients. J Neurol Sci. 2001, 190(1-2):49-55. Brighina L, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Mrazek D, Rocca WA, Maraganore DM. Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study. Parkinsonism Relat Disord. 2009, 15(6):430-4. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol. 2002, 155(8):732-8. Collins MA. Alkaloids, alcohol and Parkinson's disease. Parkinsonism Relat Disord. 2002, 8(6):417-22. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF. Intake of flavonoids and risk of dementia. Eur J Epidemiol. 2000, 16(4):357-63. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5(6):525-35. Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK, Nalbone JT, Shepherd S. Pesticide/environmental exposures and Parkinson's disease in East Texas. J Agromedicine. 2008, 13(1):37-48. Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Counsell C, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Söderkvist P, Felice A; Geoparkinson study group. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med. 2007, 64(10):666-72. Dlugos CA. Ethanol-related increases in degenerating bodies in the Purkinje neuron dendrites of aging rats. Brain Res. 2008, 1221:98-107. Dong JQ, Zhang ZX, Zhang KL. Parkinson's disease and smoking: an integral part of PD's etiological study. Biomed Environ Sci. 2003, 16(2):173-9. Eriksson AK, Löfving S, Callaghan RC, Allebeck P. Alcohol use disorders and risk of Parkinson's disease: findings from a Swedish national cohort study 1972-2008. BMC Neurol. 2013, 13:190. Evans AH, Lawrence AD, Potts J, MacGregor L, Katzenschlager R, Shaw K, Zijlmans J, Lees AJ. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006, 77(3):317-21. Fall PA, Fredrikson M, Axelson O, Granérus AK. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord. 1999, 14(1):28-37. Frigerio R, Elbaz A, Sanft KR, Peterson BJ, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Maraganore DM, Rocca WA. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology. 2005, 65(10):1575-83. Fukushima W, Miyake Y, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group. Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan. BMC Neurol. 2010, 10:111. Galanaud JP, Elbaz A, Clavel J, Vidal JS, Corrèze JR, Alpérovitch A, Tzourio C. Cigarette smoking and Parkinson's disease: a case-control study in a population characterized by a high prevalence of pesticide exposure. Mov Disord. 2005, 20(2):181-9. Gao X, Chen H, Fung TT, Logroscino G, Schwarzschild MA, Hu FB, Ascherio A. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007, 86(5):1486-94. Gerfen CR. Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 2000, 23(10 Suppl):S64-70. Gilman S, Koeppe RA, Adams KM, Junck L, Kluin KJ, Johnson-Greene D, Martorello S, Heumann M, Bandekar R. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography. Ann Neurol. 1998, 44(3):326-33. Gorell JM, Rybicki BA, Johnson CC, Peterson EL. Smoking and Parkinson's disease: a dose-response relationship. Neurology. 1999, 52(1):115-9. Hakulinen C, Elovainio M, Batty GD, Virtanen M, Kivimäki M, Jokela M. Personality and alcohol consumption: Pooled analysis of 72,949 adults from eight cohort studies. Drug Alcohol Depend. 2015 Jun 1;151:110-4. Hellenbrand W, Seidler A, Boeing H, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E, Ulm G. Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology. 1996, 47(3):636-43. Hernán MA, Chen H, Schwarzschild MA, Ascherio A. Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol. 2003, 54(2):170-5. Hernán MA, Logroscino G, Rodríguez LA. A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol. 2004, 251 Suppl 7:vII14-7. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967, 17(5):427-42. Jiménez-Jiménez FJ, Mateo D, Giménez-Roldan S. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study. Mov Disord. 1992, 7(4):339-44. Kenborg L, Lassen CF, Ritz B, Andersen KK, Christensen J, Schernhammer ES, Hansen J, Wermuth L, Rod NH, Olsen JH. Lifestyle, family history, and risk of idiopathic Parkinson disease: a large danish case-control study. Am J Epidemiol. 2015, 181(10):808-16. Kieburtz K, Wunderle KB. Parkinson's disease: evidence for environmental risk factors. Mov Disord. 2013, 28(1):8-13. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med. 1998, 339(15):1044-53. Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology. 1997, 48(6):1583-8. Liou HH, Wu CY, Chiu YH, Yen AM, Chen RC, Chen TF, Chen CC, Hwang YC, Wen YR, Chen TH. Mortality of Parkinson's disease by Hoehn-Yahr stage from community-based and clinic series [Keelung Community-based Integrated Screening (KCIS) no. 17)]. J Eval Clin Pract. 2009, 15(4):587-91. Liu R, Guo X, Park Y, Wang J, Huang X, Hollenbeck A, Blair A, Chen H. Alcohol Consumption, Types of Alcohol, and Parkinson's Disease. PLoS One. 2013, 8(6):e66452. Maclean JC, French MT. Personality disorders, alcohol use, and alcohol misuse. Soc Sci Med. 2014 Nov; 120:286-300. Marianne van der Mark, Peter C. G. Nijssen et.al, A Case-Control Study of the Protective Effect of Alcohol, Coffee, and Cigarette Consumption on Parkinson Disease Risk: Time-Since-Cessation Modifies the Effect of Tobacco Smoking. PLOS ONE 2014, 9(4): e95297 Mayeux R, Tang MX, Marder K, Côté LJ, Stern Y. Smoking and Parkinson's disease. Mov Disord. 1994, 9(2):207-12. Miller DB, O'Callaghan JP. Biomarkers of Parkinson's disease: present and future.Metabolism. 2015Mar;64(3Suppl1):S40-6. Morano A, Jiménez-Jiménez FJ, Molina JA, Antolín MA. Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain. Acta Neurol Scand. 1994, 89(3):164-70. Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Annesi G, Mari MD, Lamberti P, Grasso L, Marconi R, Epifanio A, Morgante L, Cozzolino A, Barone P, Torchia G, Quattrone A, Zappia M. Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study. Mov Disord. 2010, 25(14):2387-94. Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012, 72(6):893-901 Paganini-Hill A. Risk factors for parkinson's disease: the leisure world cohort study. Neuroepidemiology. 2001, 20(2):118-24. Palacios N, Gao X, O'Reilly E, Schwarzschild M, McCullough ML, Mayo T, Gapstur SM, Ascherio AA. Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women. Mov Disord. 2012, 27(8):980-7. Pitsavos C, Makrilakis K, Panagiotakos DB, Chrysohoou C, Ioannidis I, Dimosthenopoulos C, Stefanadis C, Katsilambros N. The J-shape effect of alcohol intake on the risk of developing acute coronary syndromes in diabetic subjects:the CARDIO2000 II Study. Diabet Med. 2005, 22(3):243-8. Ragonese P, Salemi G, Morgante L, Aridon P, Epifanio A, Buffa D, Scoppa F, Savettieri G. A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease. Neuroepidemiology. 2003, 22(5):297-304. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007, 64(7):990-7. Sieurin J, Gustavsson P, Weibull CE, Feldman AL, Petzinger GM, Gatz M, Pedersen NL, Wirdefeldt K. Personality traits and the risk for Parkinson disease: a prospective study. Eur J Epidemiol. 2015 Jul 1. Sipetic SB, Vlajinac HD, Maksimovic JM, Marinkovic JM, Dzoljic ED, Ratkov IS, Kostic VS. Cigarette smoking, coffee intake and alcohol consumption preceding Parkinson’s disease: a case-control study. Acta Neuropsychiatrica 2012, 24:109-114. Sripanyakorn S, Jugdaohsingh R, Mander A, Davidson SL, Thompson RP, Powell JJ. Moderate ingestion of alcohol is associated with acute ethanol-induced suppression of circulating CTX in a PTH-independent fashion. J Bone Miner Res. 2009, 24(8):1380-8. Thacker EL, O'Reilly EJ, Weisskopf MG, Chen H, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology. 2007 Mar 6;68(10):764-8. Tsai CH, Lo SK, See LC, Chen HZ, Chen RS, Weng YH, Chang FC, Lu CS. Environmental risk factors of young onset Parkinson's disease: a case-control study. Clin Neurol Neurosurg. 2002, 104(4):328-33. Wang WZ, Fang XH, Cheng XM, Jiang DH, Lin ZJ. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. Neuroepidemiology. 1993, 12(4):209-18. Ward RJ, Lallemand F, de Witte P, Dexter DT. Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents. Prog Neurobiol. 2008, 85(2):135-47. Wen Chiung-Jung. Evidence-based Evaluation of Preventing Progression of Hoehn-Yahr-stage-based Parkinson’s Disease with Stochastic Process. National Taiwan University, Doctoral Dissertation 2015. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011, 26 Suppl 1:S1-58. Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol. 2011, 7(5):284-94. Zhang D, Jiang H, Xie J. Alcohol intake and risk of Parkinson's disease: a meta-analysis of observational studies. Mov Disord. 2014, 29(6):819-22. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/53730 | - |
dc.description.abstract | Background
In spite of numerous studies addressing the effect of alcohol intake on the risk of Parkinson disease (PD) and several systematic reviews, the results were still controversial and inconsistent. In addition to the selection of sample and study design issues, one of important issue related to long latent period may have strong influence on the causal relationship between alcohol intake and the risk of PD. The obstacle of considering latent period is the unknown latent period that precluded the conventional statistical methods from dealing with this issue. Aims By making use a longitudinal Parkinson disease (PD) screened or a community-based integrated screening cohort with complete information on alcohol intake with dichotomous, frequency and duration of alcohol intake, this thesis aimed (1) to investigate the effect of alcohol intake on the risk of PD in terms of dichotomous property (yes/no) or three categories (current drinkers, ex-drinkers, and non-drinkers), frequency of alcohol intake, and duration of alcohol intake with adjustment for demographic features, smoking, betel nuts chewing. (2) To investigate the effect of alcohol intake on the risk of PD making allowance for different latent periods with a naïve method with adjustment for demographic features, smoking, and betel nuts chewing. (3) to provide a formal assessment of the hazard of alcohol-induced process for the development of PD compared with that of non-alcohol-induced process with a Markov and semi-Markov model; (4) to estimate the possible latent period of alcohol intake and proportion of PD attributed to alcohol intake based on the parameters obtained from (3). Materials and Methods The study population comprised two cohorts. The first cohort was included participants in the Parkinson disease (PD) screening program in 2001. A total of 9,829 eligible subjects aged over 60 formed a PD screening cohort was enrolled. Among them, a total of 55 PD cases were detected in 2001 and other 208 PD cases was diagnosed in clinical practice. The PD screened cohort with complete information on age at exposure was composed of 5061 subjects. The second cohorts included participants aged over 60 in the Keelung community-based integrated screening program during the period between 2002 and 2004. A total of 18,414 subjects including 324 PD cases were enrolled in our analysis. The combined 18,414 subjects with 5061 subjects forms a complete cohort for the analysis (N=23,475). Information on age, gender, education level, smoking, betel nut chewing, and alcohol consumption habit on age at exposure, duration of exposure, current status (quit/current), frequency by per week, and quantity for each time were collected. The logistic regression model was used to assess the alcohol intake and other risk factors associated with Parkinson disease. To tackle the alcohol-induced process start to affect the development of PD, we constructed a three-state alcohol-induced and non-alcohol-induced PD model to estimate the parameters using the empirical data from the community-based KCIS screened cohort (Keelung community-based integrated screening program). Parametric methods of Markov and semi-Markov models and non-parametric method with piecewise constant hazards were applied. According to the lethality function, the proportion for PD caused by alcohol intake was calculated based on the estimated results from the proposed models. A five-state Markov model classified by Hoehn and Yahr staging scale (H&Y scale) was developed with further consideration of covariates. Results The effect of alcohol intake (aOR: 1.03, 95% CI: 0.73-1.46) on Parkinson disease (PD) after adjusting the confounding factors was found in PD screening cohort (N=9,829) but not statistically significant. The crude odds ratios of alcohol intake were 0.70 (95% CI: 0.40-1.23) and 0.69 (95% CI: 0.51-0.95) for PD screening cohort (N=5,061) and KCIS screened cohort (N=18,414). The alcohol intake was negative associated with PD in two combined cohorts (N=23,475). After adjusting for smoking and other demographic variables, a non-significant 0.84 (95%CI: 0.62-1.15) of adjusted odds ratio for alcohol intake was found. The adjusted odds ratios were 0.67 (95%CI: 0.38-1.16) and 1.08 (95%CI: 0.71-1.64) for low and high intensity of alcohol intake, respectively. The similar findings were found in frequency and duration of alcohol intake. The odds ratio increased from 0.84% (95%CI: 0.62-1.15) without adjustment for latent period and 1.20 (95%CI: 0.85-1.69) with the adjustment for latent period when making allowance for other confounding factors. In the three-state alcohol-induced PD Markov model, the annual rate of commencing alcohol intake was estimated as 3 (95% CI: 2.95, 3.13) per 1000 person-years. The alcohol-induced and non-alcohol-induced hazards were estimated as 37 (95% CI: 29, 46) and 26 (95% CI: 23, 29) per 100,000 person years, respectively, (hazard ratio (HR) =1.42). According the lethality function of alcohol intake, the proportion for PD caused by alcohol intake was 29.73%. The semi-Markov model also suggests that both alcohol- and non-alcohol-induced hazards (HR=1.63) increased with time. The proportion for PD caused by alcohol intake was 38.73%. According to semi-Markov model, it took around 40 years of alcohol intake to render the risk of PD for those with alcohol intake higher than that for those without alcohol intake. Smokers had around 8-fold risk of alcohol intake, but had protective effects on the hazard functions to develop PD on both alcohol-induced (RR=0.95, 95% CI: 0.54, 1.66) and non-alcohol induced (RR=0.52, 95% CI: 0.38, 0.72) PD. However, regardless of smoking status, alcohol-induced hazards were still higher than non-alcohol induced. Based on the piece-wise exponential Markov model, the proportion for PD caused by alcohol intake was 25.5% for those exposed to alcohol at 20 years-old whereas this figure was reduced to 6.8% if age at exposure starts 30 years. In the natural history model for PD taking Hoehn and Yahr staging scale (H&Y scale) and detection mode into account, we found that those who ever had alcohol intake had higher risk of developing Parkinson’s disease (RR=1.62; 95% CI:1.01-2.59). Conclusions We developed a series of novel Markov and semi-Markov models to estimate the precise effect of alcohol intake on the risk of Parkinson disease (PD) taking into latent period based on a large population- and community-based screened cohort with complete information on age at exposure to alcohol and intensity of alcohol intake. The latent period we found through such a formal assessment was 40 years on which we were based to estimate 1.60-fold risk for alcohol-induced PD versus non-alcohol induced process, accounting for 39% PD cases provided the duration of alcohol is sufficient longer than the latent period. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T02:28:28Z (GMT). No. of bitstreams: 1 ntu-104-P02849006-1.pdf: 5363635 bytes, checksum: 727756537d833e590f1a66a22e64c8f5 (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 目 錄
口試委員會審定書………………………………………………………………………………………… ii 誌謝…………………………………………………………………………………………………………………… iii 英文摘要…………………………………………………………………………………………………………….iv 中文摘要…………………………………………………………………………………………………………. ix 目錄............................................. xiv CHAPTER 1. Introduction…………………………………………………….......1 CHAPTER 2. Literature review…………………………………………………...5 2.1. Epidemiological study for association between alcohol intake and Parkinson disease……………………………...5 2.1.1.Case-control study………………………....................................5 2.1.2.Prospective Cohort study………………………………………....…7 2.2 Epidemiological study for association between smoking and Parkinson disease..10 2.3 Epidemiological study for association between coffee intake and Parkinson’s disease…………………………………………………………...12 2.4. Diagnosis of Parkinson disease………………………………………….………13 2.5. Possible mechanism for alcohol intake on Parkinson’s disease……………….........................................…18 CHAPTER 3. Empirical Data and Analysis on Effect of Alcohol Intake on PD...................................21 3.1 Study Sample………………………………………………...........……………………..21 3.1.1 Study Population……………………………………………………........………….21 3.2 Data Collection…………………………………………………………………...........22 3.3 Logistic Regression Model for Analyzing the Effect of Alcohol Intake on Parkinson Disease………………………………………….………23 CHAPTER 4. Stochastic Models for Alcohol Intake and Parkinson Disease Considering Latent Period…….………….……..24 4.1 Three-state Alcohol-induced PD Model………………………………………24 4.1.1 The Markov Model……………………………………………………………..........24 4.1.2 Semi-Markov model…………………………………..………………………........26 4.1.3 Three-state Alcohol induced-Parkinson Model with Piecewise Constant Hazards……………………………………………………………….…………29 4.1.4 Lethality Function for alcohol-induced PD………………..32 4.2 Markov Model for Disease Natural History with H-Y state……………………..........................................33 CHAPTER 5. Results…………………………………………………............…………….36 5.1 Descriptive result in two cohorts………………………………………………..............................36 5.2 Alcohol intake and other risk factors associated with Parkinson disease……....................................39 5.3 Three-state Alcohol induced-Parkinson Model……………………………...................................……..45 5.4 The H-Y Natural history model for Parkinson’s disease………………………......................................…48 CHAPTER 6. Discussion………………………………………………….........………...49 6.1 Novel methodology and new findings…………………………………………...............................49 6.2 Issues to assess the effect of alcohol intake and health………………………….......................................50 6.3 Advance in methodological development…...………………....51 6.4 Application based on methodological improvement…………52 6.5 Smoking and PD……………………………………………………………….............53 6.6 Biological study in latent period………………………………………………54 6.7 Social function and Personality in alcohol consumption and risk for Parkinson disease……………………….…..55 6.8 Strengths of this study……………………………………………….....……………55 6.9Limitations……………………………………………………………………...............56 6.10 Conclusion…………………………………………………………………...............57 REFEERENCE……………………………………………………………………...................93 表目錄 Table 2-1. Literature of case-control study in association of alcohol drinking and risk of PD………......58 Table 2-2. Literature of cohort study in association of alcohol drinking and risk of PD…………………………………………………………….64 Table 5.1.1 Demographic and lifestyle factors by disease status of Parkinson disease in PD screened KCIS cohort (N=9829)………………………………………….............................……66 Table 5.1.2 Demographic and lifestyle factors by disease status of Parkinson disease among males in PD screened KCIS cohort……………………………………...........................…….67 Table 5.1.3 Demographic and lifestyle factors by disease status of Parkinson disease among females in PD screened KCIS cohort…………………………………..........................……...68 Table 5.1.4 Demographic and lifestyle factors by disease status of Parkinson disease in PD screened cohort limited to information on age at exposure available..............................................69 Table 5.1.5 Demographic and lifestyle factors by disease status of Parkinson disease in the KCIS screened cohort …………………………………………………….................................……70 Table 5.1.6 Demographic and lifestyle factors by disease status of Parkinson disease among males in the KCIS screened cohort ………………………….......................…………….71 Table 5.1.7 Demographic and lifestyle factors by disease status of Parkinson disease among females in the KCIS screened cohort ………………………………......................………..72 Table 5.2.1 Alcohol intake associated with Parkinson disease using the PD screened cohort ……………………………………….……73 Table 5.2.2 Alcohol intake associated with Parkinson disease with model adjusting for smoking and demographic variables using the PD screened cohort ………..........………74 Table 5.2.3 Frequency, duration, and intensity of alcohol intake associated with Parkinson disease using the PD screened cohort …………………………………….........................75 Table 5.2.4 Frequency, duration, and intensity of alcohol intake associated with Parkinson disease using the KCIS screened cohort ……………………………….........................….76 Table 5.2.5 Frequency, duration, and intensity of alcohol intake associated with Parkinson disease using the combined screen cohorts ……………...................…………………78 Table 5.2.6 Frequency, duration, and intensity of alcohol intake associated with Parkinson disease with model adjusting for smoking and demographic variables using the combined screen cohorts …………………………….......………………...…………80 Table 5.2.7 Alcohol intake associated with Parkinson disease with model adjusting for age at exposure, smoking, and demographic variables using the combined screen cohorts …………………………………………………………….........………………….81 Table 5.2.8 Alcohol intake associated with Parkinson disease with model adjusting for latent period using the combined screen cohorts ……………………………..................……82 Table 5.3.1 Estimated results of the three-state alcohol-induced PD Markov model................................83 Table 5.3.2 Estimated results of the three-state alcohol-induced PD semi-Markov model………………………………………………….……………..84 Table 5.3.3 Estimated results of the three-state alcohol-induced PD Markov model considering the effect of smoking on three transition rates……………………....................……85 Table 5.3.4 Estimated results of the three-state alcohol-induced PD semi-Markov model considering the effect of smoking on three transition rates………...............…………86 Table 5.3.5 The calculated θ(t) based on a three-state alcohol use-Parkinson semi-Markov model…………………………………...87 Table 5.4.1 Estimated transition rates with five-state Markov model……………......................................89 Table 5.4.2 Effects of covariates on the transition rates of five-state Markov model considering H-Y stage………….……90 圖目錄 Figure 5.3.1 The hazard rate for Parkinson’s disease based on the three-state alcohol-induced PD Markov model and the corresponding semi-Markov model………….…….............….……91 Figure 5.3.2 The hazard rate for Parkinson’s disease based on the three-state alcohol-induced PD model and the corresponding semi-Markov model considering the effect of smoking on three transition rates......................92 | |
dc.language.iso | en | |
dc.title | 以統計模式評估台灣社區研究族群的酒精飲用與巴金森氏症多階段進展 | zh_TW |
dc.title | Statistical models for evaluating the effect of alcohol consumption and risk of multistate process of Parkinson Disease using a community-based population study in Taiwan | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 劉宏輝(Horng-Huei Liou),程蘊菁(Yen-Ching Karen Chen) | |
dc.subject.keyword | 統計模式,帕金森氏症多階段進展,飲酒, | zh_TW |
dc.subject.keyword | statistical model,parkinson disease,alcohol, | en |
dc.relation.page | 98 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-08-03 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 5.24 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。